Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update.

Collaborators (27)

Author information

Affiliations

  • 1. Dana Farber Cancer Institute, Boston, MA.
      Authors
    • Burstein HJ 1
    (1 author)
  • 2. University of Pennsylvania, Philadelphia, PA.
      Authors
    • DeMichele A 2
    (1 author)
  • 3. University of Sussex, Brighton, United Kingdom.
      Authors
    • Fallowfield L 3
    (1 author)
  • 4. American Society of Clinical Oncology, Alexandria, VA.
      Authors
    • Somerfield MR 4
    (1 author)
  • 5. University of Michigan, Ann Arbor, MI.
      Authors
    • Henry NL 5
    (1 author)

ORCIDs linked to this article

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 13 Mar 2024, 42(12):1450-1453
https://doi.org/10.1200/jco.24.00248 PMID: 38478799 

Abstract 

ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).

Full text links 

Read article at publisher's site: https://doi.org/10.1200/jco.24.00248

Citations & impact 

Impact metrics

3
Citations
Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/160727056
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/160727056

Article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.